| ||
| Seattle Genetics, Astellas developing cancer drug Forbes The two said the drug targets an antigen found on several solid tumors, and in preclinical studies, it has been active on tumors of the including cancers of the bladder, breast, and lung. During the first quarter of this year, Astellas filed for ... See all stories on this topic » | ||
| The Patient Pod: The new weapon for caregivers battling hospital acquired ... Food Consumer That's more than breast cancer, car accidents and AIDS combined according to the Centers for Disease Control and Prevention. Hospitals are facing growing pressure to hold down costs and cut infection rates. Starting July 1, 2011, as part of new ... See all stories on this topic » | ||
| Healthcare Stocks: DNDN, CMN, CLSN TomRollins.com Volume traded in the last session was at 7225.00, 0.02 times the average volume. Celsion reports Drug Safety Monitoring Board recommends advancing DIGNITY study of ThermoDox in recurrent chest wall breast cancer into Phase II. See all stories on this topic » | ||
| What's news? Calgary Herald The BC Cancer Agency says cosmetics that are being handed out to patients as part of its sponsored program are safe, despite criticism that some of the products contain a class of ingredients linked to breast cancer. The agency sponsors the Look Good ... See all stories on this topic » | ||
| Model blogging about breast cancer fight in this week's Mercury Hertfordshire Mercury ... who has chosen to blog about her battle with aggressive breast cancer. A pensioner is jailed for 14 years for repeatedly raping a young girl in Hoddesdon. Police raid a suspected brothel in Waltham Cross and arrest three women on drugs offences. ... See all stories on this topic » | ||
| Retail Council of Canada Honours Excellence at National Conference DigitalJournal.com (press release) TELUS harnessed the energy of their customers, employees and leading breast cancer charities by promoting the power of pink through a milestone campaign. The Go Pink campaign was developed to support both TELUS sales and community investment objectives ... See all stories on this topic » | ||
| Lexington Man Takes Fight with Pancreatic Cancer to Capitol Patch.com "This is something where the government will have to step in as they did with breast cancer to increase funding so we can improve survival rates." On June 13 and June 14, Jayaraman will join nearly 600 concerned citizens in Washington, DC, ... See all stories on this topic » | ||
| Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Co ... PipelineReview.com (press release) Agensys is progressing a pipeline of both naked and antibody-drug conjugated (ADC) therapeutic antibodies, directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... See all stories on this topic » |
| ||
| Big Cancer Drug Meeting Yields Little for Investors | InvestorPlace By Barry Cohen One prominent oncologist said the results were exciting because the drug gives women at high-risk for breast cancer an alternative to the drug tamoxifen and to a double mastectomy just to prevent getting the disease. ... InvestorPlace | ||
| Roche Skin Cancer Drug Impresses By Zacks Investment Research Avastin, which is currently marketed worldwide for the treatment of colorectal cancer, breast cancer, NSCLC, kidney cancer and glioblastoma (a type of brain cancer), faces competition from Eli Lilly & Co.'s (NYSE:LLY) Erbitux. ... DailyMarkets.com | ||
| Are expensive cancer drugs worth the cost to Medicare? By Merrill Goozner Is a cancer prevention drug that cost $1000 a year and will, if reimbursed by Medicare, cost billions annually to reduce the incidence of breast cancer from 14 per 1000 to 10 per 1000 "essential"? Is a drug that extends the life of a ... MedCity News | ||
| Turning off cancer's growth signals | Investor Stemcell By iCELL News Around the same time, Griffith developed a personal interest in this family of cell receptors: She was diagnosed with a form of breast cancer that often overexpresses the receptor EGFR. EGFR has received much attention from biologists—the cancer drugs Erbitux, Iressa, and Tarceva all target it—but not all cancers that overexpress the EGFR respond to targeted therapies. The first highly successful targeted chemotherapy, Herceptin, goes after another member of the family, ... Investor Stemcell | ||
| Beaker » Blog Archive » Discovering the Future By Josh Baxt Dr. Mace is studying ways to overcome drug resistance in cancer, particularly Tamoxifen resistance in breast cancer. The President's Circle honors Sanford-Burnham supporters who have made gifts of $1000 or more. ... Beaker |
| ||
| Breast cancer drug pushes colon cancer cells to their death A new treatment for colon cancer that combines a chemotherapy agent approved to treat breast cancer and a cancer-fighting antibody is ready for clinical ... medicalxpress.com/.../2011-06-breast-cancer-drug-colon-cells... | ||
| New drug offers hope in preventing breast cancer - Press-Telegram Aromasin shows fewer side effects than current medications. www.presstelegram.com/news/ci_18207960 | ||
| APP Pharma launches generic breast cancer drug: Associated Press ... On Saturday, a study found that drugs like Femara cut the risk of developing breast cancer by more than half. Other drugs in the group included Aromasin and ... money.msn.com/business-news/article.aspx?feed=AP... |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment